Global NGS-Based Monitoring and Diagnostic Test 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10241885

Publication Date:

October 2, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Manufacturing (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

According to this study, the global NGS-Based Monitoring and Diagnostic Test market size will reach US$ million by 2030.
NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of NGS-Based Monitoring and Diagnostic Test market by product type, application, key players and key regions and countries.
Segmentation by product type:
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Segmentation by Application:
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Agilent Technologies, Inc.
Ancestry LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size 2024-2030
2.1.2 NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size CAGR by Region
2.2 NGS-Based Monitoring and Diagnostic Test Segment by Type
2.2.1 Commercial Assays/Tests
2.2.2 Laboratory Developed Tests
2.2.3 Direct to Consumer Test
2.2.4 Pre-Commercial Tests
2.3 NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Type
2.3.1 Global NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size 麻豆原创 Share by Type (2024-2030)
2.3.2 Global NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size Growth Rate by Type (2024-2030)
2.4 NGS-Based Monitoring and Diagnostic Test Segment by Application
2.4.1 Out-Patient Clinics/General Practitioners
2.4.2 Diagnostic Centers
2.4.3 Hospitals
2.4.4 Others
2.5 NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Application
2.5.1 Global NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size 麻豆原创 Share by Application (2024-2030)
2.5.2 Global NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size Growth Rate by Application (2024-2030)
3 NGS-Based Monitoring and Diagnostic Test Key Players
3.1 Date of Key Players Enter into NGS-Based Monitoring and Diagnostic Test
3.2 Key Players NGS-Based Monitoring and Diagnostic Test Product Offered
3.3 Key Players NGS-Based Monitoring and Diagnostic Test Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players NGS-Based Monitoring and Diagnostic Test Valuation & 麻豆原创 Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 麻豆原创 Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 NGS-Based Monitoring and Diagnostic Test by Regions
4.1 NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Regions (2024-2030)
4.2 United States NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size Growth (2024-2030)
4.3 China NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size Growth (2024-2030)
4.4 Europe NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size Growth (2024-2030)
4.5 Rest of World NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size Growth (2024-2030)
5 United States
5.1 United States NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Type (2024-2030)
5.2 United States NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Application (2024-2030)
6 Europe
6.1 Europe NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Type (2024-2030)
6.2 Europe NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Application (2024-2030)
7 China
7.1 China NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Type (2024-2030)
7.2 China NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Type (2024-2030)
8.2 Rest of World NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Key Investors in NGS-Based Monitoring and Diagnostic Test
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and 麻豆原创 Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and 麻豆原创 Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and 麻豆原创 Layout
10.4 Company D
10.5 鈥︹€�
11 Key Players Analysis
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Offered
11.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.1.4 Agilent Technologies, Inc. Main Business Overview
11.1.5 Agilent Technologies, Inc. News
11.2 Ancestry LLC
11.2.1 Ancestry LLC Company Details
11.2.2 Ancestry LLC NGS-Based Monitoring and Diagnostic Test Product Offered
11.2.3 Ancestry LLC NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.2.4 Ancestry LLC Main Business Overview
11.2.5 Ancestry LLC News
11.3 ArcherDX, Inc.
11.3.1 ArcherDX, Inc. Company Details
11.3.2 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Offered
11.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.3.4 ArcherDX, Inc. Main Business Overview
11.3.5 ArcherDX, Inc. News
11.4 Beijing Genomics Institute (BGI)
11.4.1 Beijing Genomics Institute (BGI) Company Details
11.4.2 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Offered
11.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.4.4 Beijing Genomics Institute (BGI) Main Business Overview
11.4.5 Beijing Genomics Institute (BGI) News
11.5 Cancer Genetics, Inc.
11.5.1 Cancer Genetics, Inc. Company Details
11.5.2 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Offered
11.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.5.4 Cancer Genetics, Inc. Main Business Overview
11.5.5 Cancer Genetics, Inc. News
11.6 CENTOGENE AG
11.6.1 CENTOGENE AG Company Details
11.6.2 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Offered
11.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.6.4 CENTOGENE AG Main Business Overview
11.6.5 CENTOGENE AG News
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Details
11.7.2 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Offered
11.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.7.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.7.5 F. Hoffmann-La Roche Ltd News
11.8 GenePath Dx
11.8.1 GenePath Dx Company Details
11.8.2 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Offered
11.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.8.4 GenePath Dx Main Business Overview
11.8.5 GenePath Dx News
11.9 Illumina, Inc.
11.9.1 Illumina, Inc. Company Details
11.9.2 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Offered
11.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.9.4 Illumina, Inc. Main Business Overview
11.9.5 Illumina, Inc. News
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Details
11.10.2 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Offered
11.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test 麻豆原创 Size (2024 VS 2030)
11.10.4 Laboratory Corporation of America Holdings Main Business Overview
11.10.5 Laboratory Corporation of America Holdings News
11.11 Myriad Genetics, Inc.
11.12 QIAGEN N.V.
11.13 Quest Diagnostics Incorporated
11.14 Siemens Healthineers, Inc.
11.15 Thermo Fisher Scientific Inc.
11.16 HTG Molecular Diagnostics, Inc.
11.17 Vela Diagnostics Pte. Ltd.
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.